Monitoring Agency Report for the quarter ended December 31, 2025, for Rights Issue.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences has filed the quarterly Monitoring Agency Report from India Ratings & Research for its Rights Issue. The company raised about INR 224.69 crore in January 2025 by issuing 2.04 crore equity shares at Rs 110 each. As of December 31, 2025, INR 204.89 crore (around 91%) of the revised proceeds have been used across three purposes: repaying borrowings (Rs 157.48 crore used), general corporate purposes (Rs 46.72 crore used), and issue expenses (Rs 0.69 crore, fully utilized). No deviation from the stated objects was found. About Rs 19.79 crore remains unutilized and is parked in fixed deposits with SBI. The Monitoring Agency flagged a 9-month delay in the general corporate purposes object versus the original schedule. During the quarter, Rs 1.46 crore from GCP funds was invested in Clean Max Sundarban Private Limited to set up a captive solar power plant.
This is a routine compliance filing confirming that Rights Issue proceeds are being used as planned with no misuse. The delay in deploying GCP funds and the nearly Rs 20 crore still sitting in FDs is worth tracking but is not a negative surprise since idle funds are earning interest. No material impact on share price is expected from this disclosure.